睿昂基因(688217.SH)前三季度净亏损562.07万元

Core Viewpoint - Ruiang Gene (688217.SH) reported a significant decline in revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The total operating revenue for the first three quarters of 2025 was 139 million yuan, representing a year-on-year decrease of 26.64% [1] - The net profit attributable to shareholders of the parent company was -5.62 million yuan, compared to a net profit of 5.73 million yuan in the same period last year [1] - The basic earnings per share were -0.1 yuan [1]